Pharmacodynamic target attainment of six β‐lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and …

CA DeRyke, JL Kuti, DP Nicolau - … : The Journal of Human …, 2007 - Wiley Online Library
Study Objective. To determine the likelihood that antibiotic regimens achieve bactericidal
pharmacodynamic exposures against common nosocomial pathogens. Design …

Pharmacodynamic evaluation of iv antimicrobials against Pseudomonas aeruginosa samples collected from US hospitals

RA Keel, JL Kuti, DF Sahm… - American Journal of …, 2011 - academic.oup.com
Purpose Selected iv antimicrobials were evaluated against Pseudomonas aeruginosa
isolates collected from US hospitals to predict the likelihood of achieving maximal …

Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program

HK Sun, JL Kuti, DP Nicolau - Critical care medicine, 2005 - journals.lww.com
Objective: To compare the probability of achieving specific pharmacodynamic exposures of
commonly used intravenous antibiotics for the empirical treatment of nosocomial pneumonia …

Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and …

CRV Kiffer, C Mendes, JL Kuti, DP Nicolau - Diagnostic microbiology and …, 2004 - Elsevier
The OPTAMA (Optimizing Pharmacodynamic Target Attainment using the MYSTIC
[Meropenem Yearly Susceptibility Test Information Collection] Antibiogram) Program …

In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at forty US …

KJ Eagye, JL Kuti, CA Sutherland, H Christensen… - Clinical …, 2009 - Elsevier
Background: Treatment of infections caused by gram-negative bacilli is increasingly
challenging because of emerging resistance. Current surveillance data are informative, but …

Pharmacodynamic target attainment of seven antimicrobials against Gram-negative bacteria collected from China in 2003 and 2004

H Wang, B Zhang, Y Ni, JL Kuti, B Chen, M Chen… - International journal of …, 2007 - Elsevier
Using minimum inhibitory concentration (MIC) data derived from a Chinese national
surveillance study and pharmacokinetic data collected in Chinese individuals, a 5000 …

Optimizing pharmacodynamic target attainment using the MYSTIC antibiogram: data collected in North America in 2002

JL Kuti, CH Nightingale, DP Nicolau - Antimicrobial agents and …, 2004 - Am Soc Microbiol
The OPTAMA Program is intended to examine typical antimicrobial regimens used in the
treatment of common nosocomial pathogens and the likelihood of these regimens attaining …

Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United States

P Koomanachai, CC Bulik, JL Kuti, DP Nicolau - Clinical therapeutics, 2010 - Elsevier
Background: In the era of escalating antimicrobial resistance, the choice of effective empiric
antimicrobial therapy has become considerably more difficult. In an attempt to improve …

A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the United States between 1993 and 2004

KJ Eagye, DP Nicolau, SR Lockhart, JP Quinn… - Annals of Clinical …, 2007 - Springer
Background Increasing nosocomial pathogen resistance to available antimicrobial agents is
of growing concern. While higher MICs can diminish antimicrobial effectiveness, dose …

[HTML][HTML] Continuous infusion β-lactams for intensive care unit pulmonary infections

CR Frei, DS Burgess - Clinical microbiology and infection, 2005 - Elsevier
This study evaluated the pharmacodynamics of continuous infusion β-lactams against
pulmonary isolates of Gram-negative bacteria from patients managed in intensive care units …